119 related articles for article (PubMed ID: 37459450)
1. The GR-PDK4 Axis of Evil: Hijacking a Stress SOS to Drive Metastasis.
Chakraborty AA; Keri RA
Endocrinology; 2023 Jun; 164(8):. PubMed ID: 37459450
[No Abstract] [Full Text] [Related]
2. Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4.
Dwyer AR; Perez Kerkvliet C; Truong TH; Hagen KM; Krutilina RI; Parke DN; Oakley RH; Liddle C; Cidlowski JA; Seagroves TN; Lange CA
Endocrinology; 2023 Jun; 164(7):. PubMed ID: 37224504
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor-IRS-1 axis controls EMT and the metastasis of breast cancers.
Shi W; Wang D; Yuan X; Liu Y; Guo X; Li J; Song J
J Mol Cell Biol; 2019 Dec; 11(12):1042-1055. PubMed ID: 30726932
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer.
Gandhi S; Elkhanany A; Oshi M; Dai T; Opyrchal M; Mohammadpour H; Repasky EA; Takabe K
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629782
[TBL] [Abstract][Full Text] [Related]
5. Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
Kanai A; McNamara KM; Iwabuchi E; Miki Y; Onodera Y; Guestini F; Khalid F; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Miyashita M; Ishida T; Sasano H
Breast Cancer Res Treat; 2020 Feb; 180(1):97-110. PubMed ID: 31989378
[TBL] [Abstract][Full Text] [Related]
6. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA
Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529
[TBL] [Abstract][Full Text] [Related]
7. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.
Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA
Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
West DC; Kocherginsky M; Tonsing-Carter EY; Dolcen DN; Hosfield DJ; Lastra RR; Sinnwell JP; Thompson KJ; Bowie KR; Harkless RV; Skor MN; Pierce CF; Styke SC; Kim CR; de Wet L; Greene GL; Boughey JC; Goetz MP; Kalari KR; Wang L; Fleming GF; Györffy B; Conzen SD
Clin Cancer Res; 2018 Jul; 24(14):3433-3446. PubMed ID: 29636357
[No Abstract] [Full Text] [Related]
9. GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.
West DC; Pan D; Tonsing-Carter EY; Hernandez KM; Pierce CF; Styke SC; Bowie KR; Garcia TI; Kocherginsky M; Conzen SD
Mol Cancer Res; 2016 Aug; 14(8):707-19. PubMed ID: 27141101
[TBL] [Abstract][Full Text] [Related]
10. The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.
Ritter HD; Antonova L; Mueller CR
Mol Cancer Res; 2012 Apr; 10(4):558-69. PubMed ID: 22328717
[TBL] [Abstract][Full Text] [Related]
11. Naringenin Regulates FKBP4/NR3C1/NRF2 Axis in Autophagy and Proliferation of Breast Cancer and Differentiation and Maturation of Dendritic Cell.
Xiong H; Chen Z; Lin B; Xie B; Liu X; Chen C; Li Z; Jia Y; Wu Z; Yang M; Jia Y; Wang L; Zhou J; Meng X
Front Immunol; 2021; 12():745111. PubMed ID: 35087512
[TBL] [Abstract][Full Text] [Related]
12. Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.
Zhang J; Miki Y; Iwabuchi E; Xu J; Kanai A; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Ishida T; Suzuki T; Sasano H
Breast Cancer Res Treat; 2023 Aug; 200(3):323-335. PubMed ID: 37286891
[TBL] [Abstract][Full Text] [Related]
13. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
14. The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway.
Kim SL; Choi HS; Kim JH; Lee DS
Molecules; 2020 Dec; 25(24):. PubMed ID: 33352739
[TBL] [Abstract][Full Text] [Related]
15. Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells.
Zhou L; Zhong Y; Yang FH; Li ZB; Zhou J; Liu XH; Li M; Hu F
BMB Rep; 2016 Mar; 49(3):167-72. PubMed ID: 26424557
[TBL] [Abstract][Full Text] [Related]
16. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.
Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD
Breast Cancer Res; 2019 Jul; 21(1):82. PubMed ID: 31340854
[TBL] [Abstract][Full Text] [Related]
18. STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer.
Conway ME; McDaniel JM; Graham JM; Guillen KP; Oliver PG; Parker SL; Yue P; Turkson J; Buchsbaum DJ; Welm BE; Myers RM; Varley KE
Cancer Res; 2020 Oct; 80(20):4355-4370. PubMed ID: 32816914
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of Glucocorticoid Signaling.
Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-κB signaling.
Senthil Kumar KJ; Gokila Vani M; Hsieh HW; Lin CC; Liao JW; Chueh PJ; Wang SY
Carcinogenesis; 2019 Apr; 40(2):335-348. PubMed ID: 30726934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
